Menu
GeneBe

MESP2

mesoderm posterior bHLH transcription factor 2, the group of Basic helix-loop-helix proteins

Basic information

Region (hg38): 15:89760590-89778754

Links

ENSG00000188095NCBI:145873OMIM:605195HGNC:29659Uniprot:Q0VG99AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • spondylocostal dysostosis 2, autosomal recessive (Definitive), mode of inheritance: AR
  • spondylocostal dysostosis 2, autosomal recessive (Strong), mode of inheritance: AR
  • autosomal recessive spondylocostal dysostosis (Supportive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Spondylocostal dysostosis 2, autosomal recessiveARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingMusculoskeletal15214000; 15122512; 18485326; 20301771

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MESP2 gene.

  • not provided (333 variants)
  • Spondylocostal dysostosis 2, autosomal recessive (102 variants)
  • not specified (25 variants)
  • Inborn genetic diseases (13 variants)
  • Spondylocostal dysostosis (3 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MESP2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
206
clinvar
4
clinvar
212
missense
65
clinvar
6
clinvar
3
clinvar
74
nonsense
13
clinvar
10
clinvar
6
clinvar
29
start loss
1
clinvar
1
frameshift
11
clinvar
3
clinvar
13
clinvar
27
inframe indel
7
clinvar
3
clinvar
4
clinvar
14
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
12
clinvar
8
clinvar
4
clinvar
24
Total 24 13 106 223 15

Highest pathogenic variant AF is 0.000171

Variants in MESP2

This is a list of pathogenic ClinVar variants found in the MESP2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
15-89776082-T-C Benign (Jun 20, 2021)1224835
15-89776088-G-A Benign (Jun 20, 2021)1276179
15-89776347-G-A not specified • Spondylocostal dysostosis Likely benign (Jun 14, 2016)257238
15-89776358-A-G not specified Uncertain significance (Nov 16, 2023)2682567
15-89776361-GC-G Pathogenic (Mar 03, 2022)2106318
15-89776363-C-T Likely benign (Sep 27, 2023)1079839
15-89776368-C-A Spondylocostal dysostosis 2, autosomal recessive Pathogenic/Likely pathogenic (Apr 12, 2023)554878
15-89776368-CGCCTCCTCCGCAGA-C Pathogenic (Nov 24, 2021)1452062
15-89776368-C-CGCCTCCTCCGCAGA Pathogenic (Dec 21, 2021)1453610
15-89776375-T-A Spondylocostal dysostosis 2, autosomal recessive Likely benign (Jul 11, 2023)1148593
15-89776377-C-A Uncertain significance (Feb 04, 2022)1428670
15-89776378-G-A Likely benign (Apr 05, 2023)2847043
15-89776378-G-T Likely benign (Mar 26, 2022)2117220
15-89776381-G-A Likely benign (Dec 17, 2021)2044710
15-89776387-C-T Likely benign (Jun 13, 2022)1983222
15-89776390-C-A Likely benign (Jan 30, 2024)2806588
15-89776393-C-G Likely benign (Nov 17, 2023)1079286
15-89776397-G-T Uncertain significance (Oct 01, 2022)2162892
15-89776400-C-G Inborn genetic diseases Uncertain significance (Nov 21, 2023)3125392
15-89776404-G-A Pathogenic (Nov 07, 2021)1441772
15-89776405-G-A Spondylocostal dysostosis 2, autosomal recessive Likely pathogenic (Jun 27, 2017)552595
15-89776405-GA-G Spondylocostal dysostosis 2, autosomal recessive Pathogenic (Oct 24, 2023)2627573
15-89776415-C-T Pathogenic (Feb 08, 2023)1455327
15-89776420-C-A Likely benign (Dec 04, 2022)3011170
15-89776424-G-A Spondylocostal dysostosis 2, autosomal recessive • MESP2-related disorder Likely benign (Jan 25, 2024)731465

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MESP2protein_codingprotein_codingENST00000341735 218161
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000003110.5631247310201247510.0000802
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1872042120.9640.00001192438
Missense in Polyphen3438.6710.87922550
Synonymous-0.01611031031.000.00000656873
Loss of Function0.8341013.30.7535.88e-7132

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006720.0000646
Ashkenazi Jewish0.00009950.0000993
East Asian0.0005690.000557
Finnish0.000.00
European (Non-Finnish)0.00006600.0000618
Middle Eastern0.0005690.000557
South Asian0.00003320.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Transcription factor with important role in somitogenesis. Defines the rostrocaudal patterning of the somite by participating in distinct Notch pathways. Regulates also the FGF signaling pathway. Specifies the rostral half of the somites. Generates rostro-caudal polarity of somites by down-regulating in the presumptive rostral domain DLL1, a Notch ligand. Participates in the segment border formation by activating in the anterior presomitic mesoderm LFNG, a negative regulator of DLL1-Notch signaling. Acts as a strong suppressor of Notch activity. Together with MESP1 is involved in the epithelialization of somitic mesoderm and in the development of cardiac mesoderm.;
Disease
DISEASE: Spondylocostal dysostosis 2, autosomal recessive (SCDO2) [MIM:608681]: A condition of variable severity associated with vertebral and rib segmentation defects. The main skeletal malformations include fusion of vertebrae, hemivertebrae, fusion of certain ribs, and other rib malformations. Deformity of the chest and spine (severe scoliosis, kyphoscoliosis and lordosis) is a natural consequence of the malformation and leads to a dwarf- like appearance. As the thorax is small, infants frequently have respiratory insufficiency and repeated respiratory infections resulting in life-threatening complications in the first year of life. {ECO:0000269|PubMed:15122512}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Cardiac Progenitor Differentiation;Gene regulatory network modelling somitogenesis (Consensus)

Recessive Scores

pRec
0.141

Haploinsufficiency Scores

pHI
0.108
hipred
N
hipred_score
0.187
ghis
0.437

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.125

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Mesp2
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; skeleton phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); muscle phenotype; cellular phenotype; growth/size/body region phenotype;

Zebrafish Information Network

Gene name
mespab
Affected structure
determination of heart left/right asymmetry
Phenotype tag
abnormal
Phenotype quality
decreased efficacy

Gene ontology

Biological process
mesoderm formation;somitogenesis;heart morphogenesis;Notch signaling pathway;positive regulation of transcription by RNA polymerase II
Cellular component
nucleus
Molecular function
RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;protein dimerization activity